Severe COVID-19 Adults Patients To Be Treated With 'Tocilizumab'

For the treatment of Covid-19 patients, the DCGI on September 6 approved Hetero's Tocilizumab vaccine for emergency use. It will be used for adults receiving systemic corticosteroids or requires oxygen supply. "We are pleased with approval... crucial to supply security in India considering a global shortage of Tocilizumab. we will be working closely with the government to ensure equitable distribution," said Dr. B. Partha Saradhi Reddy, Hetero Group Chairman.